Millions of service members, veterans and military families could see their prescription drug costs drop significantly under a newly introduced bill aimed at extending Medicare‑style drug price protections to other federal health programs.
The proposal, known as the MISSION RX Act, was introduced this week by Democratic Representatives Pat Ryan of New York and Eugene Vindman of Virginia, both Army veterans.
The law is designed to allow people enrolled in TRICARE and the Department of Veterans Affairs health system to pay the lowest government‑negotiated price for prescription medications.
Why It Matters
Prescription drug costs remain one of the most significant and often overlooked financial pressures facing veterans, service members and military families.
While Medicare recipients have recently begun benefiting from federal drug price negotiations, those enrolled in TRICARE and the VA health system have largely been left out, despite also relying on government‑run healthcare.
What To Know
Under current law, only people enrolled in Medicare benefit from the federal government’s authority to negotiate prices for certain high‑cost prescription drugs, which was a power granted under the Inflation Reduction Act of 2022.
The new bill would extend that pricing structure so that both TRICARE beneficiaries and VA health system patients pay whichever price is lower: the rate already negotiated by Medicare or the price available through their existing coverage.
Lawmakers say the change could save families thousands of dollars per year, especially those who rely on brand‑name drugs for chronic conditions.
“Military families have sacrificed so much for this country – it’s absolutely unacceptable that they’re being forced to pay more than other Americans for the same medication,” Ryan said in a statement.
“Our bill corrects this egregious oversight by ensuring that military families have access to the same lower drug prices that others do. Especially amid rising healthcare costs nationwide, leaving military families to bear the burden is simply un-American. They’ve stepped up and sacrificed for us – now we need to do right by them.”
According to the Defense Health Agency, TRICARE provides coverage to roughly 9.6 million people, including active‑duty service members, retirees, National Guard and Reserve members, and their families.
In addition, millions of veterans receive care through the VA health system, and they would also be impacted.
Lawmakers sponsoring the bill say extending Medicare‑negotiated prices could significantly reduce out‑of‑pocket costs for this group, who currently do not automatically benefit from federal price‑setting even though they receive government‑administered healthcare.
“As healthcare costs continue to rise across the country, the MISSION RX Act is a straightforward approach to reduce prescription drug costs,” Democratic Representative Chrissy Houlahan of Pennsylvania, former Air Force officer, said in a statement. “As the Centers for Medicaid Services negotiate reduced prices for citizens on Medicare and Medicaid, it only makes sense to pass those same lower prices to the people who sacrificed the most for our nation: our veterans and military families.”
Veterans organizations including the Veterans of Foreign Wars, Marine Corps League and Air Force Sergeants Association have expressed support for the legislation.
The MISSION RX Act builds directly on Medicare’s price‑negotiation framework, which the Centers for Medicare & Medicaid Services has said is already saving billions annually on select medications.
“The bill simply asks why TRICARE and the VA are still paying the higher, pre-negotiated rate for the exact same drugs. There’s no policy justification for that gap,” Michael Ryan, finance expert and founder of MichaelRyanMoney.com, told Newsweek. “A veteran filling a cancer prescription shouldn’t pay more than a Medicare recipient filling the same prescription just because of which federal program covers them.”
By opening access to those negotiated prices, the cosponsors said, the policy would lower individual out‑of‑pocket drug costs and reduce federal spending on prescriptions.
It would also create consistent pricing standards across federal health programs and save up to $6 billion annually for taxpayers overall, according to Ryan’s office.
“If the estimated savings hold true, passage becomes much more realistic because lawmakers can frame it as both a veterans issue and a fiscal efficiency measure,” Kevin Thompson, CEO of 9i Capital Group and host of the 9innings podcast, told Newsweek. “The bigger question is who ultimately absorbs the cost difference within the healthcare and pharmaceutical system.”
What Happens Next
The bill has been formally introduced in the House and now faces the early stages of the legislative process, including committee consideration. Its future is uncertain, particularly given the narrow Republican majority in the chamber.
“If the federal government has already secured a lower price for medication, the VA or TRICARE having to pay a higher price is not only not efficient, but it’s also costing taxpayers billions of additional dollars annually,” Alex Beene, financial literacy instructor for the University of Tennessee at Martin, told Newsweek.
“This bill would be an attempt to actually make good on prior promises of offering prescription drug savings to groups that desperately need them.”
